Exane Derivatives’s UGI UGI Stock Holding History

Exane Derivatives’s Portfolio UGI Stock Details UGI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-61	Closed	-$2.21K	–	964
2022 Q1	$2.21K	Buy	+61	New	+$2.44K	﹤0.01%	744
2021 Q4	–	Sell	-61	Closed	-$2.6K	–	1016
2021 Q3	$2.6K	Sell	61 -1,779	-97%	-$81.3K	﹤0.01%	786
2021 Q2	$84.1K	Sell	1,840 -104	-5%	-$4.68K	0.02%	566
2021 Q1	$79.7K	Buy	1,944 +1,927	+11,335%	+$74.5K	0.02%	455
2020 Q4	$594	Sell	17 -30,049	-100%	-$1.05M	﹤0.01%	725
2020 Q3	$992K	Buy	+30,066	New	+$997K	0.29%	84
2017 Q2	–	Sell	-57,386	Closed	-$2.83M	–	682
2017 Q1	$2.83M	Sell	57,386 -30,913	-35%	-$1.47M	0.64%	44
2016 Q4	$4.07M	Sell	88,299 -86,421	-49%	-$3.87M	0.8%	31
2016 Q3	$7.9M	Buy	+174,720	New	+$7.97M	1.19%	33

Other funds holding UGI

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

First Eagle Investment Management New York $59.9B AUM 27.01% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

SCM

Snyder Capital Management San Francisco, California $5.79B AUM 33.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Diamond Hill Capital Management Columbus, Ohio $12.5B AUM 7.49% 1-Year Est. Return

Exane Derivatives's UGI Position: Q2 2022 in Review

Exane Derivatives sold out of UGI (UGI) in Q2 2022, closing a stake of 61 shares — an estimated $2.21K sold.

Exane Derivatives first reported a position in UGI in Q3 2016 and held it in 9 quarters. The position peaked at $7.9M in Q3 2016. 531 funds tracked by Wall St. Rank hold UGI as of Q2 2022.

Exane Derivatives reported no remaining UGI position as of Q2 2022 after selling out during the quarter.
Exane Derivatives sold 61 UGI shares in Q2 2022, an estimated $2.21K.
Exane Derivatives first reported a position in UGI in Q3 2016 and held it in 9 quarters.
Exane Derivatives's UGI position peaked at $7.9M in Q3 2016.
531 funds tracked by Wall St. Rank held UGI as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.